{
  "ticker": "BIO",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02964163",
  "id": "02964163",
  "pages": 5,
  "price_sensitive": true,
  "date": "20250701",
  "time": "0844",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250701/pdf/06l9lztk3lml5y.pdf",
  "summary": "### Summary of Material Information:  \n- **Record Sales Revenue**:  \n  - FY25 unaudited sales revenue: **$18.4m** (up **41%** vs. FY24).  \n  - Q4 FY25 sales: **$5m** (up **33%** vs. PCP).  \n  - June 2025 monthly sales: **$2.1m** (up **50%** vs. PCP).  \n- **Annualized Run Rate**: **$20m** (based on Q4 performance).  \n- **Profitability**: Expects **positive EBITDA for Q4** and **first full-year net profit in FY25**.  \n- **Growth Targets**: On track for **$75m+ cumulative sales** under \"Vision 27\" (FY25\u2013FY27).  \n- **International Expansion**: Secured new retailers/distributors in Canada, UK, Ireland, and NZ; update expected July 2025.  \n\n*No capital markets actions (e.g., raising, halt) identified.*",
  "usage": {
    "prompt_tokens": 1884,
    "completion_tokens": 218,
    "total_tokens": 2102,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-30T22:55:10.208424"
}